PMID: 6401950Jan 1, 1983Paper

The transdermal administration of nitrates: an overview

Angiology
F J Demma, R R Wilson

Abstract

Nitroglycerin has been the mainstay of the medical management of angina pectoris for over 100 years. The long-held clinical impression of the efficacy of nitroglycerin has now been clearly documented in controlled clinical trials designed to evaluate objective response to antianginal agents. Advances in scientific methodology and improved experimental design have contributed to continuing interest in nitrates. Newer uses of nitroglycerin and other nitrates in congestive heart failure and acute myocardial infarction are the result of a developing understanding of the pharmacology of nitrates.

References

Dec 1, 1977·Angiology·G S Francis, A D Hagan
May 19, 1978·JAMA : the Journal of the American Medical Association·J A Miner, R Conti
Aug 1, 1976·The American Journal of Cardiology·J O ParkerP W Armstrong
Oct 1, 1976·The American Journal of Cardiology·W R TaylorH J Swan
Oct 1, 1976·The American Journal of Cardiology·P W ArmstrongJ O Parker
Oct 1, 1976·British Heart Journal·S G MeisterW S Frankl
May 3, 1980·Lancet·L H Opie
May 29, 1980·The New England Journal of Medicine·J Abrams
Oct 1, 1980·The American Journal of Cardiology·P W ArmstrongG S Marks
Sep 1, 1955·The American Journal of the Medical Sciences·J A DAVIS, B H WIESEL

❮ Previous
Next ❯

Citations

Aug 1, 1994·Cardiovascular Drugs and Therapy·U Thadani, R J Lipicky
Dec 1, 1986·The Japanese Journal of Psychiatry and Neurology·K FukudaT Okuma
Jul 1, 1985·Biopharmaceutics & Drug Disposition·S H Curry, S M Aburawi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.